{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:57:54Z","timestamp":1762865874696},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00428-011-1178-7","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T08:44:15Z","timestamp":1323074655000},"page":"89-93","source":"Crossref","is-referenced-by-count":16,"title":["Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung"],"prefix":"10.1007","volume":"460","author":[{"given":"Mitchell L.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Yuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana V.","family":"Yeldandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra L.","family":"Zynger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2010.03.015","volume":"58","author":"AB Stillebroer","year":"2010","unstructured":"Stillebroer AB, Mulders PFA, Boerman OC et al (2010) Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Eur Urol 58:75\u201383","journal-title":"Eur Urol"},{"issue":"3","key":"1178_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lungcan.2006.08.017","volume":"54","author":"H Kon-no","year":"2006","unstructured":"Kon-no H, Ishii G, Nagai K et al (2006) Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer 54(3):409\u2013418","journal-title":"Lung Cancer"},{"key":"1178_CR3","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","volume":"25","author":"BC Leibovich","year":"2007","unstructured":"Leibovich BC, Sheinin Y, Lohse CM et al (2007) Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol 25:4757\u20134764","journal-title":"J Clin Oncol"},{"key":"1178_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2008.10.001","volume":"64","author":"F Malentacchi","year":"2009","unstructured":"Malentacchi F, Simi L, Nannelli C et al (2009) Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Lung Cancer 64:271\u2013276","journal-title":"Lung Cancer"},{"issue":"2","key":"1178_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.23496","volume":"123","author":"J Patard","year":"2009","unstructured":"Patard J, Fergelot P, Karakiewicz PI et al (2009) Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer 123(2):395\u2013400","journal-title":"Int J Cancer"},{"issue":"3","key":"1178_CR6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","volume":"158","author":"S Ivanov","year":"2001","unstructured":"Ivanov S, Liao SY, Ivanova A et al (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158(3):905\u2013919","journal-title":"Am J Pathol"},{"key":"1178_CR7","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.ejca.2010.07.020","volume":"46","author":"J Tostain","year":"2010","unstructured":"Tostain J, Li G, Gentil-Perret A et al (2010) Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer 46:3141\u20133148","journal-title":"Eur J Cancer"},{"key":"1178_CR8","first-page":"2827","volume":"57","author":"SY Liao","year":"1997","unstructured":"Liao SY, Aurelio ON, Jan K et al (1997) Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57:2827\u20132831","journal-title":"Cancer Res"},{"key":"1178_CR9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","volume":"134","author":"EM Genega","year":"2010","unstructured":"Genega EM, Ghebremichael M, Najarian R et al (2010) Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. Am J Clin Pathol 134:873\u2013879","journal-title":"Am J Clin Pathol"},{"key":"1178_CR10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1464-410X.2005.05615.x","volume":"96","author":"JT Leppert","year":"2005","unstructured":"Leppert JT, Lam JS, Pantuck AJ et al (2005) Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int 96:281\u2013285","journal-title":"BJU Int"},{"issue":"3","key":"1178_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181570343","volume":"32","author":"HA Al-Hamadie","year":"2008","unstructured":"Al-Hamadie HA, Alden D, Qin LX et al (2008) Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies. Am J Surg Pathol 32(3):377\u2013382","journal-title":"Am J Surg Pathol"},{"key":"1178_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-5347(17)54359-1","volume":"126","author":"DW McNichols","year":"1981","unstructured":"McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126:17\u201323","journal-title":"J Urol"},{"key":"1178_CR13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","volume":"30","author":"NK Janzen","year":"2003","unstructured":"Janzen NK, Kim HL, Figlin RA et al (2003) Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30:843\u2013852","journal-title":"Urol Clin North Am"},{"key":"1178_CR14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H","volume":"80","author":"RM Bukowski","year":"1997","unstructured":"Bukowski RM (1997) Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer 80:1198\u20131220","journal-title":"Cancer"},{"key":"1178_CR15","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2002.11.123","volume":"20","author":"RJ Motzer","year":"2002","unstructured":"Motzer RJ, Bacik J, Mariani T et al (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20:2376\u20132381","journal-title":"J Clin Oncol"},{"key":"1178_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/187152009788680028","volume":"9","author":"JY Winum","year":"2009","unstructured":"Winum JY, Scozzafava A, Montera JL et al (2009) Inhibition of carbonic anhydrase IX: a new strategy against cancer. Anticancer Agents Med Chem 9:693\u2013702","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"1178_CR17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/13547500601068192","volume":"12","author":"G Li","year":"2007","unstructured":"Li G, Passebosc-Faure K, Feng G et al (2007) MN\/CA9: a potential gene marker for detection of malignant cells in effusions. Biomarkers 12(2):214\u2013220","journal-title":"Biomarkers"},{"key":"1178_CR18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605690","volume":"102","author":"M Ilie","year":"2010","unstructured":"Ilie M, Mazure NM, Hofman V et al (2010) High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 102:1627\u20131635","journal-title":"Br J Cancer"},{"key":"1178_CR19","volume-title":"World Health Organization classification of tumors: pathology and genetics of tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2004","unstructured":"Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) World Health Organization classification of tumors: pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon"},{"key":"1178_CR20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1464-410X.2010.09218.x","volume":"106","author":"TK Choueiri","year":"2010","unstructured":"Choueiri TK, Regan MM, Rosenberg JE et al (2010) Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. BJU Int 106:772\u2013778","journal-title":"BJU Int"},{"key":"1178_CR21","first-page":"802","volume":"9","author":"MH Bui","year":"2003","unstructured":"Bui MH, Seligson D, Han K et al (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9:802\u2013811","journal-title":"Clin Cancer Res"},{"key":"1178_CR22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.juro.2006.11.100","volume":"177","author":"SK Tickoo","year":"2007","unstructured":"Tickoo SK, Alden D, Olgac S (2007) Immunohistochemical expression of hypoxia inducible factor-1\u03b1 and its downstream molecules in sarcomatoid renal cell carcinoma. J Urol 177:1258\u20131263","journal-title":"J Urol"},{"key":"1178_CR23","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1158\/1078-0432.CCR-04-0636","volume":"10","author":"SJ Kim","year":"2004","unstructured":"Kim SJ, Rabbani ZN, Vollmer RT (2004) Carbonic anhydrase IX in early-stage non-small cell lung cancer. Clin Cancer Res 10:7925\u20137933","journal-title":"Clin Cancer Res"},{"key":"1178_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.lungcan.2005.03.036","volume":"49","author":"SJ Kim","year":"2005","unstructured":"Kim SJ, Rabbani ZN, Dewhirst MW (2005) Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325\u2013335","journal-title":"Lung Cancer"},{"key":"1178_CR25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1034\/j.1399-3003.1999.14d14.x","volume":"14","author":"P Vermylen","year":"1999","unstructured":"Vermylen P, Roufosse C, Burny A (1999) Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J 14:806\u2013811","journal-title":"Eur Respir J"},{"issue":"10","key":"1178_CR26","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1158\/1078-0432.CCR-04-2019","volume":"11","author":"M Atkins","year":"2005","unstructured":"Atkins M, Regan M, McDermott D (2005) Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11(10):3714\u20133721","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1178_CR27","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cncr.24231","volume":"115","author":"MB Atkins","year":"2009","unstructured":"Atkins MB, Choueiri TK, Cho D (2009) Treatment selection for patients with metastatic renal cell carcinoma. Cancer 115(10):2327\u20132333","journal-title":"Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1178-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-011-1178-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1178-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T09:01:29Z","timestamp":1561021289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-011-1178-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s00428-011-1178-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}